Literature DB >> 15138245

Prevalence of chlamydial and gonococcal infections among young adults in the United States.

William C Miller1, Carol A Ford, Martina Morris, Mark S Handcock, John L Schmitz, Marcia M Hobbs, Myron S Cohen, Kathleen Mullan Harris, J Richard Udry.   

Abstract

CONTEXT: Chlamydial and gonococcal infections are important causes of pelvic inflammatory disease, ectopic pregnancy, and infertility. Although screening for Chlamydia trachomatis is widely recommended among young adult women, little information is available regarding the prevalence of chlamydial and gonococcal infections in the general young adult population.
OBJECTIVE: To determine the prevalence of chlamydial and gonococcal infections in a nationally representative sample of young adults living in the United States. DESIGN, SETTING, AND PARTICIPANTS: Cross-sectional analyses of a prospective cohort study of a nationally representative sample of 14,322 young adults aged 18 to 26 years. In-home interviews were conducted across the United States for Wave III of The National Longitudinal Study of Adolescent Health (Add Health) from April 2, 2001, to May 9, 2002. This study sample represented 66.3% of the original 18,924 participants in Wave I of Add Health. First-void urine specimens using ligase chain reaction assay were available for 12,548 (87.6%) of the Wave III participants. MAIN OUTCOME MEASURES: Prevalences of chlamydial and gonococcal infections in the general young adult population, and by age, self-reported race/ethnicity, and geographic region of current residence.
RESULTS: Overall prevalence of chlamydial infection was 4.19% (95% confidence interval [CI], 3.48%-4.90%). Women (4.74%; 95% CI, 3.93%-5.71%) were more likely to be infected than men (3.67%; 95% CI, 2.93%-4.58%; prevalence ratio, 1.29; 95% CI, 1.03-1.63). The prevalence of chlamydial infection was highest among black women (13.95%; 95% CI, 11.25%-17.18%) and black men (11.12%; 95% CI, 8.51%-14.42%); lowest prevalences were among Asian men (1.14%; 95% CI, 0.40%-3.21%), white men (1.38%; 95% CI, 0.93%-2.03%), and white women (2.52%; 95% CI, 1.90%-3.34%). Prevalence of chlamydial infection was highest in the south (5.39%; 95% CI, 4.24%-6.83%) and lowest in the northeast (2.39%; 95% CI, 1.56%-3.65%). Overall prevalence of gonorrhea was 0.43% (95% CI, 0.29%-0.63%). Among black men and women, the prevalence was 2.13% (95% CI, 1.46%-3.10%) and among white young adults, 0.10% (95% CI, 0.03%-0.27%). Prevalence of coinfection with both chlamydial and gonococcal infections was 0.030% (95% CI, 0.18%-0.49%).
CONCLUSIONS: The prevalence of chlamydial infection is high among young adults in the United States. Substantial racial/ethnic disparities are present in the prevalence of both chlamydial and gonococcal infections.

Entities:  

Mesh:

Year:  2004        PMID: 15138245     DOI: 10.1001/jama.291.18.2229

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  203 in total

1.  A new murine model for testing vaccines against genital Chlamydia trachomatis infections in males.

Authors:  Sukumar Pal; Annahita K Sarcon; Luis M de la Maza
Journal:  Vaccine       Date:  2010-10-13       Impact factor: 3.641

2.  Bridging the gap: using school-based health services to improve chlamydia screening among young women.

Authors:  Rebecca A Braun; Jackie M Provost
Journal:  Am J Public Health       Date:  2010-07-15       Impact factor: 9.308

Review 3.  Beyond "safe sex"--can we fight adolescent pelvic inflammatory disease?

Authors:  Bahaa Abu Raya; Ellen Bamberger; Nogah C Kerem; Aharon Kessel; Isaac Srugo
Journal:  Eur J Pediatr       Date:  2012-07-10       Impact factor: 3.183

4.  Gender and race as correlates of high risk sex behaviors among injection drug users at risk for HIV enrolled in the HPTN 037 study.

Authors:  Mandy J Hill; Michael Holt; Brett Hanscom; Zhe Wang; Marylou Cardenas-Turanzas; Carl Latkin
Journal:  Drug Alcohol Depend       Date:  2018-01-04       Impact factor: 4.492

5.  Intranasal vaccination with a secreted chlamydial protein enhances resolution of genital Chlamydia muridarum infection, protects against oviduct pathology, and is highly dependent upon endogenous gamma interferon production.

Authors:  Ashlesh K Murthy; James P Chambers; Patricia A Meier; Guangming Zhong; Bernard P Arulanandam
Journal:  Infect Immun       Date:  2006-11-21       Impact factor: 3.441

6.  Completeness of reporting of race and ethnicity data in the nationally notifiable diseases surveillance system, United States, 2006-2010.

Authors:  Nelson Adekoya; Benedict I Truman; Umed A Ajani
Journal:  J Public Health Manag Pract       Date:  2015 Mar-Apr

7.  Increased immunoaccessibility of MOMP epitopes in a vaccine formulated with amphipols may account for the very robust protection elicited against a vaginal challenge with Chlamydia muridarum.

Authors:  Delia F Tifrea; Sukumar Pal; Jean-Luc Popot; Melanie J Cocco; Luis M de la Maza
Journal:  J Immunol       Date:  2014-04-28       Impact factor: 5.422

8.  Sexually transmitted infections among HIV-infected heavy drinkers in St Petersburg, Russia.

Authors:  C A Pace; D Lioznov; D M Cheng; S E Wakeman; A Raj; A Y Walley; S M Coleman; C Bridden; E Krupitsky; J H Samet
Journal:  Int J STD AIDS       Date:  2012-12       Impact factor: 1.359

9.  Serovar-specific immune responses to peptides of variable regions of Chlamydia trachomatis major outer membrane protein in serovar D-infected women.

Authors:  Pragya Srivastava; Rishein Gupta; Hem Chandra Jha; Rajneesh Jha; Apurb Rashmi Bhengraj; Sudha Salhan; Aruna Mittal
Journal:  Clin Exp Med       Date:  2008-09-25       Impact factor: 3.984

10.  The Influence of Role Status on Risky Sexual Behavior Among African Americans During the Transition to Adulthood.

Authors:  Steven M Kogan; Gene H Brody; Frederick X Gibbons; Velma McBride Murry; Carolyn E Cutrona; Ronald L Simons; Gina Wingood; Ralph Diclemente
Journal:  J Black Psychol       Date:  2008-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.